Literature DB >> 21525856

The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychoses.

Aristotle N Voineskos1, Jason P Lerch, Daniel Felsky, Arun Tiwari, Tarek K Rajji, Dielle Miranda, Nancy J Lobaugh, Bruce G Pollock, Benoit H Mulsant, James L Kennedy.   

Abstract

Schizophrenia and bipolar disorder share genetic risk, brain vulnerability, and clinical symptoms. The ZNF804A risk variant, rs1344706, confers susceptibility for both disorders. This study aimed to identify neural mechanisms common to both schizophrenia and bipolar disorder through this variant's potential effects on cortical thickness, white matter tract integrity, and cognitive function. Imaging, genetics, and cognitive measures were ascertained in 62 healthy adults aged between 18 and 59 years. High-resolution multimodal MRI/DTI imaging was used to measure cortical thickness and major frontotemporal and interhemispheric white matter tracts. The general linear model was used to examine the influence of the ZNF804A rs1344706 risk variant on cortical thickness, white matter tract integrity, and cognitive measures. Individuals homozygous for the risk variant ('A' allele) demonstrated reduced cortical gray matter thickness in the superior temporal gyrus, and in the anterior and posterior cingulate cortices compared with C-allele carriers. No effect of the risk variant on microstructural integrity of white matter tracts was found. Reduced attention control was found in risk allele homozygotes, aligning with findings in the anterior cingulate cortex. Our data provide a novel, genetically based neural risk mechanism for the major psychoses by effects of the ZNF804A risk variant on neural structures and cognitive function susceptible in both disorders. Our findings link genetic, imaging, and cognitive susceptibility relevant to both schizophrenia and bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525856      PMCID: PMC3154105          DOI: 10.1038/npp.2011.72

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  53 in total

1.  Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI.

Authors:  D MacDonald; N Kabani; D Avis; A C Evans
Journal:  Neuroimage       Date:  2000-09       Impact factor: 6.556

2.  Thresholding of statistical maps in functional neuroimaging using the false discovery rate.

Authors:  Christopher R Genovese; Nicole A Lazar; Thomas Nichols
Journal:  Neuroimage       Date:  2002-04       Impact factor: 6.556

Review 3.  Processing and visualization for diffusion tensor MRI.

Authors:  C-F Westin; S E Maier; H Mamata; A Nabavi; F A Jolesz; R Kikinis
Journal:  Med Image Anal       Date:  2002-06       Impact factor: 8.545

4.  Virtual in vivo interactive dissection of white matter fasciculi in the human brain.

Authors:  Marco Catani; Robert J Howard; Sinisa Pajevic; Derek K Jones
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

Review 5.  Neuropsychology of bipolar disorder: a review.

Authors:  Seema Quraishi; Sophia Frangou
Journal:  J Affect Disord       Date:  2002-12       Impact factor: 4.839

6.  Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis.

Authors:  Alex P Zijdenbos; Reza Forghani; Alan C Evans
Journal:  IEEE Trans Med Imaging       Date:  2002-10       Impact factor: 10.048

7.  Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers.

Authors:  Shi K Liu; Chia-Hui Chiu; Ching-Jui Chang; Tzung-Jeng Hwang; Hai-Gwo Hwu; Wei J Chen
Journal:  Am J Psychiatry       Date:  2002-06       Impact factor: 18.112

8.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Authors:  Dmitri Tkachev; Michael L Mimmack; Margaret M Ryan; Matt Wayland; Tom Freeman; Peter B Jones; Michael Starkey; Maree J Webster; Robert H Yolken; Sabine Bahn
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

9.  Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia.

Authors:  Kiyoto Kasai; Martha E Shenton; Dean F Salisbury; Yoshio Hirayasu; Chang-Uk Lee; Aleksandra A Ciszewski; Deborah Yurgelun-Todd; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

10.  Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study.

Authors:  Marek Kubicki; Carl-Fredrik Westin; Paul G Nestor; Cynthia G Wible; Melissa Frumin; Stephan E Maier; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton
Journal:  Biol Psychiatry       Date:  2003-12-01       Impact factor: 13.382

View more
  28 in total

1.  Evidence of IQ-modulated association between ZNF804A gene polymorphism and cognitive function in schizophrenia patients.

Authors:  Min Chen; Zhansheng Xu; Jinguo Zhai; Xin Bao; Qiumei Zhang; Huang Gu; Qiuge Shen; Lina Cheng; Xiongying Chen; Keqin Wang; Xiaoxiang Deng; Feng Ji; Chuanxin Liu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2012-02-29       Impact factor: 7.853

2.  A schizophrenia risk gene, ZNF804A, is associated with brain white matter microstructure.

Authors:  T Ikuta; B D Peters; S Guha; M John; K H Karlsgodt; T Lencz; P R Szeszko; A K Malhotra
Journal:  Schizophr Res       Date:  2014-03-27       Impact factor: 4.939

3.  ZNF804A and cortical structure in schizophrenia: in vivo and postmortem studies.

Authors:  Carl Christoph Schultz; Igor Nenadic; Brien Riley; Vladimir I Vladimirov; Gerd Wagner; Kathrin Koch; Claudia Schachtzabel; Thomas W Mühleisen; Buket Basmanav; Markus M Nöthen; Thomas Deufel; Michael Kiehntopf; Marcella Rietschel; Jürgen R Reichenbach; Sven Cichon; Ralf G M Schlösser; Heinrich Sauer
Journal:  Schizophr Bull       Date:  2013-09-27       Impact factor: 9.306

4.  Category fluency, latent semantic analysis and schizophrenia: a candidate gene approach.

Authors:  Kristin K Nicodemus; Brita Elvevåg; Peter W Foltz; Mark Rosenstein; Catherine Diaz-Asper; Daniel R Weinberger
Journal:  Cortex       Date:  2013-12-20       Impact factor: 4.027

Review 5.  The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions.

Authors:  H Chang; X Xiao; M Li
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

6.  No association of ZNF804A rs1344706 with white matter integrity in schizophrenia: a tract-based spatial statistics study.

Authors:  Qinling Wei; Zhuang Kang; Feici Diao; Arnaud Guidon; Xiaoli Wu; Liangrong Zheng; Leijun Li; Xiaofeng Guo; Maorong Hu; Jinbei Zhang; Chunlei Liu; Jingping Zhao
Journal:  Neurosci Lett       Date:  2012-11-09       Impact factor: 3.046

7.  Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.

Authors:  Aristotle N Voineskos; Daniel Felsky; Anne L Wheeler; David J Rotenberg; Melissa Levesque; Sejal Patel; Philip R Szeszko; James L Kennedy; Todd Lencz; Anil K Malhotra
Journal:  Schizophr Bull       Date:  2015-12-27       Impact factor: 9.306

Review 8.  The relationship of developmental changes in white matter to the onset of psychosis.

Authors:  Katherine H Karlsgodt; Sarah C Jacobson; Marc Seal; Paolo Fusar-Poli
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

9.  Replication of ZNF804A gene variant associations with risk of heroin addiction.

Authors:  D B Hancock; J L Levy; N C Gaddis; C Glasheen; N L Saccone; G P Page; L J Bierut; A H Kral; E O Johnson
Journal:  Genes Brain Behav       Date:  2015-10-20       Impact factor: 3.449

10.  Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706.

Authors:  Ran Tao; Helena Cousijn; Andrew E Jaffe; Philip W J Burnet; Freya Edwards; Sharon L Eastwood; Joo Heon Shin; Tracy A Lane; Mary A Walker; Brady J Maher; Daniel R Weinberger; Paul J Harrison; Thomas M Hyde; Joel E Kleinman
Journal:  JAMA Psychiatry       Date:  2014-10       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.